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Abstract: Understanding the mechanisms leading to the rise and dissemination of antimicrobial re-
sistance (AMR) is crucially important for the preservation of power of antimicrobials and controlling
infectious diseases. Measures to monitor and detect AMR, however, have been significantly delayed
and introduced much later after the beginning of industrial production and consumption of antimi-
crobials. However, monitoring and detection of AMR is largely focused on bacterial pathogens, thus
missing multiple key events which take place before the emergence and spread of AMR among the
pathogens. In this regard, careful analysis of AMR development towards recently introduced antimi-
crobials may serve as a valuable example for the better understanding of mechanisms driving AMR
evolution. Here, the example of evolution of tet(X), which confers resistance to the next-generation
tetracyclines, is summarised and discussed. Initial mechanisms of resistance to these antimicro-
bials among pathogens were mostly via chromosomal mutations leading to the overexpression of
efflux pumps. High-level resistance was achieved only after the acquisition of flavin-dependent
monooxygenase-encoding genes from the environmental microbiota. These genes confer resistance
to all tetracyclines, including the next-generation tetracyclines, and thus were termed tet(X). ISCR2
and IS26, as well as a variety of conjugative and mobilizable plasmids of different incompatibility
groups, played an essential role in the acquisition of tet(X) genes from natural reservoirs and in
further dissemination among bacterial commensals and pathogens. This process, which took place
within the last decade, demonstrates how rapidly AMR evolution may progress, taking away some
drugs of last resort from our arsenal.
Keywords: tetracyclines; next-generation tetracyclines; antimicrobial resistance; natural reservoirs;
mobile genetic elements; horizontal gene transfer
1. Introduction
In 2009, I analysed the phylogeny of relatively few tet(X) genes (spelling of tetracycline-
resistant determinants in this article follows the nomenclature by Levy and others [1])
discovered at that time, which belong to the A family of flavin-dependent monooxygenases
(FMOs) which are widely distributed in a variety of natural microbiota [2]. This interest
has been dictated by the fact that Tet X enzymes are capable of efficient inactivation of tetra-
cyclines, including the representative of the third-generation tetracyclines, tigecycline [3,4].
This drug (the minocycline derivative 9-tert-butyl-glycylamido-minocycline, GAR-936),
was approved by the FDA in 2005 and by the EMA in 2006. Tigecycline appeared to be very
effective against a broad range of bacterial pathogens, including those resistant to the first-
and second-generation tetracyclines [2]. Resistance levels among Gram-negative pathogens
were considered to be low and, in general, caused by mutations leading to the overexpres-
sion of efflux pumps belonging to the resistance nodulation division (RND) family. The
risk of horizontal transfer of this non-specific RND resistance machinery among bacterial
pathogens (and among any other bacteria for that matter) is low because they belong to the
core constituents of bacterial genomes, they are complex, and they have evolved to perform
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a variety of specific functions within the cell other than antimicrobial resistance. On the
contrary, evolutionary trajectories of genes encoding FMOs are incongruent with the genes
of core genomes, such as encoding translation machinery (16S rRNA gene, for example)
and suggest past horizontal exchange and duplication events [2]. The current genetic
context of tet(X) has been also analysed, showing a potential for horizontal gene transfer
(HGT) [2]. It has been concluded that the above prerequisites could make FMOs/Tet Xs the
most likely mechanisms for the emergence of a high-level resistance to third-generation
tetracyclines among bacterial pathogens. Thus, a possible mobilisation of FMO-encoding
genes from environmental reservoirs and their dissemination into pathogenic microbiota
should be closely monitored and intervened if necessary.
The situation with tet(X) was reassessed in 2013 [5]. At that time, the first indication
of movement of tet(X) into clinical settings was reported [6]. In a hospital in Sierra Leone,
21% of isolates from urinary tract infections were confirmed to be tet(X)-positive. The
range of multidrug-resistant (MDR) Gram-negative pathogens included Enterobacter cloacae,
Comamonas testosteroni, Escherichia coli, Klebsiella pneumoniae, Delftia acidovorans, Enterobacter
sp., and other members of the Enterobacteriaceae and Pseudomonadaceae families. The au-
thors also noted that tigecycline was not available locally, but 87% of pharmacies dispensed
the first- and second-generation tetracyclines without prescription [6]. Thus, the selective
pressure imposed by the older tetracyclines may have driven the rise and spread of tet(X),
which confers resistance to the third-generation tetracycline. Moreover, the authors also
indicated the presence of mobile genetic elements (MGEs) in some isolates, which could
serve as vehicles for tet(X) transmission and dissemination.
Selection by older tetracyclines could have been responsible for the emergence of tet(X)
in food animals as well. In fact, the presence of tet(X) in an animal pathogen, Riemerella
anatipestifer, was reported even earlier, in 2010 [7]. This bacterium causes septicaemia
anserum exsudativa [8], which results in major economic losses in duck production [9,10].
The R. anatipestifer strain was reported in 2010 [7]; however, it was actually isolated in
2005. The strain carries plasmid pRA0511, which encodes two chloramphenicol acetyltrans-
ferases, a multi-drug ABC transporter permease/ATPase, and Tet X. Analysis of seven
R. anatipestifer genomic sequences available at that time revealed that tet(X) was present
in three genomic sequences but was undetectable in the other four genomes [5]. A few
years later the situation changed drastically: it has been found that 80.2% of R. anatipestifer
isolates from ducks possess the tet(X) gene [11]. Thus, during this very short timeframe,
enzymatic inactivation has become the main mechanism of tetracycline resistance in R.
anatipestifer, well surpassing other mechanisms of resistance such as ribosomal protection
and drug efflux.
In brief, in the 2013 tet(X) update [5], it has been concluded that the major selective
force responsible for the dissemination of this gene, which encodes resistance to the
newer tetracycline(s), is actually not the use of the newer, but older tetracyclines. The
newer tetracycline(s) are considered to be drugs of last resort and their use is limited,
usually confined to controlled clinical settings. On the contrary, the use of the older
tetracyclines is much less regulated, and they are used in vast quantities, especially in
agriculture [12]. This broader and more extensive selection base in agriculture may lead to
the accelerated evolution toward resistance to newer antimicrobial(s). Moreover, there is
a widespread horizontal gene exchange among different ecological compartments of the
global microbiota [13], which may contribute to the dissemination of agriculturally selected
antimicrobial resistance (AMR) genes to human microbiota. Agricultural use of antibiotics
is considered to be one of the major contributors to the global AMR problem, leading to
the rise of untreatable human infections, thus resulting in public health crises [14]. Thus,
given our past failures to deal with antimicrobial resistance due to the lack of knowledge,
currently we are in a better position to finally implement the measures necessary to preserve
the power of newer antimicrobials [5].
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2. Present Situation with tet(X)
Unfortunately, however, during the past two years there have been an explosive num-
ber of publications showing that the worst-case scenario with the extensive dissemination
of tet(X) into pathogenic microbiota is actively taking place, especially in China [15–18].
Current epidemiological data indicate that the variants of tet(X), tet(X3)/(X4)/(X5/X6/X14),
can be detected in various ecological compartments in China, including humans and ani-
mals (mainly pigs, chickens, and ducks) [11,15–22]. According to a recent epidemiological
analysis [18], the highest occurrence of Tet X-producing isolates has been recorded in
China—42, followed by Sierra Leone—5, USA—4, Hungary—3, the Americas—1, the
Czech Republic—1, France—1, and Japan—1. Worryingly, these tet(X) variants confer
higher resistance levels against tigecycline, they are located on MGEs, and they are be-
ginning to emerge in known human pathogens such as Acinetobacter species (especially
A. baumannii) and Enterobacteriaceae [23,24]. Even more troublesome is the ability of these
Tet X variants to degrade other next-generation tetracyclines such as eravacycline [25] and
omadacycline [26]. In 2018, the FDA approved the former drug for therapy of complex
intra-abdominal infections, and the latter — for treatment of community-acquired bac-
terial pneumonia and acute skin and skin structure infections [27]. For example, tet(X5),
which was detected in a clinical A. baumannii isolate from China in 2017, confers universal
resistance to all classes of tetracyclines, including tetracycline, doxycycline, minocycline,
tigecycline, eravacycline, and omadacycline [28]. The same resistance phenotypes were
detected among tet(X3–X5)-carrying Acinetobacter species isolated from different ecolog-
ical niches across China [19]. The tet(X4)-carrying E. coli, which was detected in several
provinces in China, was found to be capable of degrading all tetracyclines, including
tigecycline and the newly approved eravacycline [16]. This tet(X4) gene is harboured by
the IncQ1 plasmid, which is highly transferable to a number of clinical and laboratory
strains within the Enterobacteriaceae family. Moreover, in can be stably maintained in
transconjugants under non-selective conditions, suggesting that the fitness cost of the
plasmid carriage is not significant [16]. The rise of the easily transferable resistance to
the recently approved latest generations of tetracyclines, which can be stably inherited by
pathogenic bacteria, is of concern because this severely compromises the contemporary
arsenal of drugs of last resort.
3. Diversity of FMO-Encoding and tet(X) Genes
The currently identified range of Tet X variants include Tet X–Tet X14, with a variable
level of amino acid sequence identity, with the lowest similarity between Tet X and Tet
X14 at 67% [29]. Presumably, this is a reflection of natural diversity of FMOs that have
been acquired from different taxonomic entities and different ecological niches. It has been
suggested, for example, that the pool of tet(X7-X13) genes is mainly associated with the
gastrointestinal tract, while one of them, tet(X7), is also detectable in a clinical Pseudomonas
aeruginosa isolate [30]. However, tet(X8–X13) are currently represented only by metage-
nomic sequences, and their association with disease-causing bacteria remains unclear.
The range of natural diversity of FMOs, to which Tet Xs belong, is extraordinary and
includes a wide variety of enzymes involved in different oxygenation reactions [31]. These
broad spectra are also reflected in the ability to destroy a range of antimicrobials, which
presently include tetracyclines, rifampicins, sulfonamides, and β-lactams [32]. Besides
tetracyclines, which are discussed here, these targets, for example, are represented by
aromatic polyketides such as rifampicins [33–35]. Another class B FMO can oxidise the
carbonyl moiety of the β-lactam ring, thus conferring resistance to imipenem [36]. The
targets even include antimicrobials that are completely synthetic and have no pre-existing
structural analogues in natural ecosystems such as sulphonamides. The well-known mecha-
nism of sulphonamide resistance includes the sul genes encoding modified dihydropteroate
synthases [37]. A newly emerging mechanism of resistance to sulphonamides involves
a two-component FMO that can catabolise these antimicrobials, and the location of the
corresponding genes in the vicinity of traA suggests a potential for HGT [38]. Similarly,
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a recently identified class D FMO is capable of degrading sulphonamides, and the corre-
sponding gene, sulX, is associated with MGEs [39]. Thus, due to their abundance in the
environmental microbiota and broad substrate capacity, FMOs are capable of inactivating
a number of antimicrobials of different classes via oxygenation reactions [32]. Although
there are substantial structural differences between the older and newer generations of
tetracyclines, a variety of FMO/Tet X enzymes are capable of degrading all of them [19,28].
Compared to the inactivation of other classes of antimicrobials, however, FMOs that de-
grade tetracyclines appeared to be more reproductively successful in Darwinian terms and
disseminated into a large group of Gram-negative bacteria, including pathogens.
4. Phylogeny of tet(X) Genes
Previous phylogenetic analyses suggested that the FMO-encoding genes from the
group of environmental bacteria belonging to the Flavobacteriaceae family are most
likely to be the origin of the tet(X) genes [18,19]. Indeed, the vast diversity of genes
encoding tetracycline-inactivating monooxygenases resides within the species belong-
ing to the Cytophaga, Fusobacterium, and Bacteroides (CFB) group bacteria (alternative
naming—Bacteroidetes phylum, consisting of Bacteroidia, Flavobacteriia and Sphingobac-
teriia classes) (Figures 1 and 2). It appeared to be that one species within the Flavobacteriia
class, i.e., R. anatipestifer, is the most prominent bacterium in representing the majority
of tet(X) diversity. The question that immediately arises then is whether this a natural
diversity or a product of artificial selection? If it is a natural diversity, what could have
been the driving force(s) behind this diversity? Bacteria may face a wide variety of xeno-
biotic compounds that have to be detoxified, and thus it is difficult to ascertain what
the natural targets for FMOs have been before the start of industrial production of tetra-
cyclines. Presently, no environmental factors that could have played this role could be
admissibly propositioned. As mentioned before, this bacterium is a pathogen infecting
mainly ducks and geese and causing a septicaemic disease, leading to significant losses in
the industry. The recommended disease treatments are enrofloxacin in drinking water or
subcutaneous/intramuscular injection of penicillin [40,41]. Thus, the disease treatment by
these antimicrobials cannot be a direct selective force leading to the over-representation
of tet(X) alleles in R. anatipestifer populations. The most probable selective force in this
case could be tetracyclines which are extensively used for growth-promoting purposes,
but not for disease treatment. This long-term selection by tetracyclines in duck farms may
have resulted in the extensive diversification and enrichment of R. anatipestifer populations
with a variety of tet(X) alleles that can currently be seen. There is a need to emphasise here
that several Tet X clades consist entirely of this species (Figures 1 and 2), from which tet(X)
variants may potentially spread to other bacteria, including pathogenics.
In the E.U. countries, growth-promoting antibiotics were banned from January 1,
2006, when all these antibiotics, including tetracyclines, were deleted from the Community
Register of authorised feed additives [42]. In the United States, tetracyclines were no longer
allowed for growth promotion after January 1, 2017 [43]. Despite these regulatory measures,
however, the use of antibiotics, including older tetracyclines such as chlortetracycline and
oxytetracycline, in farm animals still remains a tenacious issue [44]. It is mainly associated
with the current model of industrial production of inexpensive protein, which depends,
to a great extent, on the use of antimicrobials. There are no specific data concerning
tetracycline use in duck production in China, but it has been estimated [45] that tetracyclines
(chlortetracycline and oxytetracycline) are the most used antibiotics in food animals there,
including in broiler poultry (613,120 kg), swine (16,336,823 kg), and possibly others.
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Figure 1. Phylogenetic reconstruction of flavin-dependent monooxygenase (FMO)/Tet X evolution produced with fast
minimum evolution algorithm [46] using FMO and Tet X amino acid sequences predicted from gene sequences. The
dataset of 76 non-redundant amino acid sequence was retrieved from GenBank using the Tet X2 sequence from Bacteroides
fragilis (GenBank accession number WP_063856436) as a query (highlighted in yellow). Uncultured/environmental sample
sequences were excluded from the analysis. Sequences were aligned using Constraint-based Multiple Alignment Tool
(Cobalt) at the NCBI site (https://www.ncbi.nlm.nih.gov/tools/cobalt/cobalt.cgi, accessed on 8 March 2021). Amino
acid positions from 11 to 388 were used to construct the tree. FAD-dependent monooxygenase from Pedobacter sp. ASV28
(GenBank accession number WP_199119858.1) was used to root the tree. MULTISPECIES indicates that identical amino acid
sequences were present in multiple species. The scale bar is in fixed amino acid substitutions per sequence position. Nodes
and branches of the CFB group bacteria (Bacteroidetes phylum) are in blue, Gammaproteobacteria in yellow, Enterobacteria
in green, and unspecified bacteria in grey.
Another interesting aspect is the dissemination of tet(X) variants within the Tet X–X2
clade, which contains the tet(X) genes initially identified in Bacteroides species (Figure 1).
The ancestral clade for it is represented by the corresponding protein in R. anatipestifer,
with further entry into the other R. anatipestifer species and the representatives of the
Bacteroidales order, consisting of Bacteroides, Parabacteroides and Prevotella species. These
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species are anaerobic gut bacteria, which raises a question as to why tet(X) is carried
by these bacteria because the enzyme encoded requires oxygen and is presumably not
functional under anaerobic conditions.
Figure 2. Expansion of the branch with 31 organisms in Figure 1. All corresponding designations are the same as in Figure 1.
Apparently, other flavobacteria may also serve as reservoirs of the tet(X) genes, from
which they may be acquired by other, unrelated bacteria. For example, the ancestral clade
for Tet X3, which includes Acinetobacter species, can be identified within a taxonomically
unrelated flavobacterium, Empedobacter brevis (Figure 1). Within the clade, there are a
large number of identical protein sequences. For example, the branch marked as “MUL-
TISPECIES: tetracycline-inactivating monooxygenase Tet(X3) [Acinetobacter]” consists of
288 identical protein sequences detected in the genomes of different Acinetobacter species.
This indicates the key role played by MGEs and HGT in the spread of tet(X3) among the
Acinetobacter species.
The origin of some clades, however, could not be tracked back to the R. anatipes-
tifer or another Flavobacteriia ancestry. Clade Tet X4, for example, comprises protein
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sequences that could be identified only within the enterobacteria and Gammaproteobac-
teria (Figures 1 and 2). The MULTISPECIES branch consists of 409 identical proteins, 361
of which are identified in E. coli genomes. Other identical sequences can be detected
in Acinetobacter indicus—4, A. towneri—2, Acinetobacter species—5, Aeromonas caviae—2,
Citrobacter braakii—1, C. freundii—2, Escherichia fergusonii—1, Klebsiella pneumoniae—3, K.
quasipneumoniae—1, various Salmonella enterica serovars—23, Shigella flexneri—2, and S.
sonnei—2. Phylogenetic analysis suggests that the protein-encoding gene was acquired
from an E. coli ancestor, with further dissemination into other E. coli strains, as well as
to the representatives of enterobacteria and Gammaproteobacteria. The presence of the
identical protein sequences in a diverse group of 409 bacteria within Gammaproteobacteria
discussed above strongly supports the role of MGEs and HGT in dissemination of the
tet(X4) gene.
Similarly, no involvement of any flavobacteria in the role of the tet(X) reservoir could
be presumed for another clade, which consists solely of the Gammaproteobacteria repre-
sentatives (Figure 2). In summary, these observations suggest the polyphyletic origin of
tet(X) genes, which were recruited from natural reservoirs of FMO-encoding genes residing
within different taxonomic entities. The currently identified sources are Flavobacteriia and
Gammaproteobacteria, with the prominent role displayed by a representative of the former
class, R. anatipestifer.
5. The Role of MGEs in Acquisition and Dissemination of tet(X) Genes
5.1. The Role of IS Elements in tet(X) Evolution
With the exception of the prototype tet(X/X2), genetic context surrounding other
tet(X) genes is almost uniformly associated with ISCR2 or IS26, occasionally in combina-
tion [15–19,23,24,28,47]. Sometimes, ISCR2 is called ISVsa3 [48]; here, ISCR2 will be used
for the sake of consistency. ISCR (CR = common region) elements represent one of the
most powerful gene-capturing systems, invented by bacteria, to sample and present the
DNA acquired in a different cellular and genomic context [49]. Due to transposition via
the rolling-circle replication mechanism, ISCRs, unlike the majority of IS elements, do not
need two intact copies to transpose, and thus provide a very high rate of transposition
compared to other IS elements. The process of gene sampling and presentation is random,
but if its function is necessary in a new cellular environment, a gene becomes embedded in
a new host. This is especially true for AMR genes that protect against the lethal action of
antimicrobials. Indeed, ISCRs are linked to providing protective mechanisms against many
antimicrobials of different classes [49].
The same authors also suggested that ISCR elements may have originated from aquatic
bacteria [49]. This origin may be shared by a member of this family, ISCR2, as well. The
wide distribution of ISCR2 throughout multiple diverse aquatic genera, including Vibrio,
Shewanella, Pseudoalteromonas and Psychrobacter, suggests its role in dissemination of AMR
genes [50]. For example, one of the first florfenicol-resistant genes isolated, floR, was
associated with ISCR2, and was detected on a plasmid from the fish pathogen Pasteurella
damsalae subsp. piscida. This archetypal genetic context, with close association with ISCR2
and floR, still persists, and can be frequently encountered in tigecycline-resistant bacteria,
in combination with the recently acquired tet(X) variants [15,16,18,22–24,47].
Another genetic background associated with the tet(X) genes includes IS26, which is
encountered less frequently than ISCR2, although sometimes these two ISs can be seen in
combination, with ISCR2 being encased by IS26 [18,22,24]. IS26 transposes via replicative
mechanism and plays an important role in the reorganisation of plasmids that harbour
genes, conferring resistance to a variety of antimicrobials [51]. IS26 also preferentially
transposes within plasmids over the chromosomes, thus contributing to HGT of AMR
genes and the emergence of MDR phenotypes, especially in clinically significant bacteria.
In the course of evolution, IS26s have been selected as a natural genetic engineering
tool, allowing extensive plasmid restructuring and reassortment. The plasmid diversity
generated serves as a starting material for the selection of plasmids that provide better
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protection of host cells against environmental challenges. Antimicrobial selection is one
of these stern challenges, and the presence of IS26-generated diversity of plasmids with
multiple drug-resistant determinants in clinical isolates [49] indicate a successful strategy
implemented by bacteria to withstand the selective pressure of antimicrobials imposed by
humans. More importantly, the role of IS26 in restructuring and generation, for example,
of novel multiple tet(X4)-carrying plasmid variants, was confirmed experimentally, during
conjugation experiments under controlled laboratory conditions [24]. Thus, the combined
effect of these two ISs, ISCR2 and IS26, has been a major driving force that provided the
rapid expansion of tet(X) into a variety of Gram-negative bacteria, some of which are
known pathogens.
5.2. The Role of Plasmids in tet(X) Dissemination
The next step in intra- and inter-species horizontal dissemination of AMR genes
among bacteria involves plasmids, conjugative transposons, integrative conjugative ele-
ments, bacteriophages, and other MGEs capable of intercellular transmission of genetic
information. One of the earliest indications of the role played by ISCR2 and IS26 in the
acquisition and dissemination of tet(X) was obtained with plasmids, which were captured
into E. coli recipients from soil microbiota by conjugation [52]. Interestingly, laboratory con-
jugation experiments with these plasmids showed a tendency for genetic rearrangements
and chromosomal integration, presumably due to the presence of ISCR2 and IS26. The
authors concluded that Acinetobacter spp. were probably putative hosts for these plasmids
in soil, which was a worrying sign because the closely related MDR A. baumannii was
already identified as a major nosocomial infection and listed among ESKAPE pathogens
requiring immediate attention [53–55].
Regrettably, however, the worst-case scenario has taken place during the past decade.
Several tet(X) variants that are located on plasmids and confer high level resistance to the
next-generation tetracyclines, tigecycline, eravacycline and omadacycline, can be found in
human and animal isolates of Acinetobacter species, including A. baumannii [15,19,22,28].
Acquisition and dissemination of these tet(X) variants was mediated via ISCR2 and IS26
transposition into a variety of conjugative and mobilizable plasmids belonging to different
incompatibility groups. Transfer of these tet(X)-bearing plasmids into A. baumannii strains
circulating in the hospital environment may lead to the failure of therapies by drugs of
last resort such as the next-generation tetracyclines. It should be noted here that ISCR2
and IS26 are highly spread among the clinical isolates of Acinetobacter spp., including
A. baumannii [56], and these transposition mechanisms are crucial in supplying a rapid
diversification of the acquired gene repertoire from other ecological compartments. Some
of the genes that provide a better protection against antimicrobials could then be selected
in, and inherited by, the survived host cells and assume the role of AMR genes. We still
do not know exactly what the natural function/activity of FMOs, which are currently
named as Tet Xs, is. In our practice, these genes have been found as conferring resistance
towards several generations of tetracyclines; therefore, we call them tet genes, although
their original function(s) in nature may be different.
Plasmid-mediated high-level resistance to the next-generation tetracyclines may be-
come problematic for the corresponding treatment of Enterobacteriaceae infections as well.
Enormous diversity of tet(X)-bearing plasmids of different incompatibility groups has
been recently recovered just from a single slaughterhouse [24]. The plasmids isolated
from 74 strains of E. coli and one strain of Providencia rettgeri were classified as ColE2-like,
IncQ, IncX1, IncA/C2, IncFII, IncFIB, as well as hybrid plasmids with different replicons.
Analogously to the case with tet(X)-bearing Acinetobacter species, this work emphasised
the important role played by ISCR2 and IS26 in acquisition and dissemination of the tet(X)
genes within the Enterobacteriaceae family as well. Moreover, the role of IS26 in MDR
plasmid reorganisation and generation of novel plasmid diversity was also experimentally
confirmed [24].
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Other studies have also reported a wide dissemination of tet(X)-bearing plasmids
in Enterobacteriaceae, especially in E. coli, in a variety of environments, including food-
producing animals and their environments, slaughterhouses, raw meat, hospitals, and in
communities [15–17,24,47,57]. Interestingly, resistance to the next-generation tetracyclines
in E. coli plasmids is almost exclusively encoded by the tet(X4) gene, while a broader
diversity of tet(X) genes is carried by plasmids within Acinetobacter species.
5.3. The Role of Conjugative Transposons and Integrative Conjugative Elements (ICEs)
The initially identified Tet X1 and Tet X2-encoding sequences were located on a
CTnDOT transposon from a human gut commensal bacterium Bacteroides thetaiotaomicron,
which may also be widely distributed in a variety of other intestinal Bacteroides species [58]).
The tet(X) gene in an environmental Sphingobacterium sp. strain was also found on a
transposon-like element, Tn6031, which is very similar to CTnDOT [59].
A recent large-scale surveillance of clinical tet(X)-carrying Gram-negative bacterial
isolates showed that the largest proportion of these genes can be seen among the repre-
sentatives of the Flavobacteriaceae family compared to Enterobacteriaceae or Acinetobacter
species [18]. In Flavobacteriaceae, the genetic context of tet(X) was usually associated with
the chromosomally located ICEs. Additionally, unlike the plasmid-located tet(X) genes,
there were hardly any traces of association with ISCR2 and IS26, except for two strains of
Chryseobacterium bernardetii, where partially deleted ISCR2s were detectable. Although the
Flavobacteriaceae strains reported were of clinical origin, representatives of this family
are usually environmental bacteria and inhabit various aquatic and terrestrial ecosystems.
Most likely, these isolates were also of environmental origin, causing opportunistic in-
fections in immunocompromised patients. In general, however, the role of conjugative
transposons and ICEs in the dissemination of tet(X) seems less prominent compared to the
plasmid-mediated HGT.
6. Emergence and Rise of AMR: From Chromosomal Mutations to Acquired
Mobile Resistance
During the last decade, we had a unique opportunity to monitor the real-time evolu-
tion and dissemination of an AMR gene, tet(X). All previous examples of this kind have
been severely limited, mainly due to the delayed detection, often only after a post factum
emergence in pathogenic microbiota. Potential reservoirs, especially environmental, and
the ways of acquisition of AMR genes from these reservoirs are difficult to reconstruct, if
no extensive monitoring efforts are implemented. The long-term and widespread use of
antimicrobials make the monitoring programs even more difficult because of extensive
coverage necessary and the lack of reference points in most cases. Only in a very lim-
ited number of cases it is possible to reveal the original reservoir and putative transfer
event resulting in the acquisition of an AMR gene by bacterial pathogens. This attain-
ment could be, for example, illustrated by the emergence and dissemination of the mobile
qnr genes, which confer resistance to quinolones. This has been initially described in
a clinical K. pneumoniae strain isolated in 1994 [60]. Further analysis of qnrA-like genes
established that an aquatic bacterium, Shewanella algae, is the natural reservoir for the
qnrA genes [61]. Within the currently recognised seven families of qnr genes, the origin
of some of them could be tracked to a variety of taxonomically and ecologically distant
bacteria such as C. freundii (qnrB), Vibrionaceae (qnrC), Enterobacter spp. (qnrE), and Vibrio
splendidus (qnrS) [62,63]. The most probable functional role of these pentapeptide repeat
proteins in nature is the involvement in some steps of DNA metabolism involving stress
responses, which also happened to be useful in the protection of DNA replication against
quinolones. Initially, however, resistance to quinolones was due to chromosomal mutations,
leading to target modification or by either decreased uptake or increased efflux. Only later
were these resistance mechanisms enhanced by the acquisition and wide dissemination of
transferrable quinolone-resistant genes mediated by MGEs. Initially, these mechanisms
remained obscure, but from 1998 onward they spread in epidemic proportions [62]. This
enabled breaking of the constraints imposed by chromosomal mutations, which restricted
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the spread of AMR to vertical inheritance and clonal dissemination. Instead, a widespread
dissemination of AMR became possible that overcomes taxonomic and ecological barriers.
Similarly, the initial mechanisms of tigecycline resistance were also due to chromo-
somal mutations that led to the overexpression of efflux pumps. In clinical isolates of
A. baumannii, for example, the initial reduced susceptibility towards the drug was due to
the elevated expression of the RND family of efflux pumps, AdeABC and AdeIJK [64,65].
In E. cloacae and E. coli as well, reduced tigecycline susceptibility was due to the elevated
expression of another efflux pump in the RND family, AcrAB [66,67]. In general, these
efflux mechanisms are non-specific, and their overexpression is due to chromosomal muta-
tions affecting the regulatory network [64]. The efflux systems, which are chromosomally
located, consist of several genes, and they are tightly integrated into the cellular regulatory
network, with limited chances for acquisition and dissemination via MGEs. Even in the
original hosts, the non-specific drug efflux only offers marginal protection. However, these
mechanisms provide intermediate protection and survival, before the arrival of genes that
are capable of delivering high-level drug resistance. Generation of such a potential gene
pool and its exposure to other cellular contexts is a continuous process driven by MGEs,
which results in extensive HGT within and among different ecological compartments [13].
Some genes in a new cellular environment thus could occasionally confer resistance to
antimicrobials and then are selected as AMR genes. This scenario has been possibly insti-
gated in the case of FMOs, some of which happened to have enzymatic activities capable
of destructing certain antimicrobials including the next-generation tetracyclines [32]. This
chain of events leading to the rise and dissemination of tet(X) is depicted in Figure 3.




Figure 3. Schematic representation of tet(X) evolution. 
An initial step in the process of acquisition of mobile resistance towards all tetracy-
clines could have been the in situ selection and enrichment of natural reservoirs of tet(X) 
in order to reach the critical threshold density, which is crucial for MGEs to operate via 
conjugation mechanisms and provide successful HGT. This enrichment, especially in fla-
vobacteria and Gammaproteobacteria, probably resulted from the extensive selection by 
older tetracyclines, and most likely in agricultural settings where they are mainly used, 
both in proportional and absolute terms. Analysis of the tet(X) diversity (Figures 1 and 2) 
demonstrated that it largely resides within R. anatipestifer. A recent retrospective screen-
ing of 212 R. anatipestifer isolates from 58 large-scale duck farms in different regions of 
China demonstrated that 90.6% of them are resistant to tetracycline [11]. Interestingly, 
80.2% of these isolates possessed the tet(X) gene, while the next most frequent tetracycline-
resistant gene, tet(A), was encountered only in 20.8% of isolates. Moreover, if isolates that 
carry tet(X) were counted in combination with other tetracycline-resistant genes, the total 
tet(X)-carriage rate by this bacterium reaches 99.6%. Moreover, tet(X) could be transferred 
to a tetracycline-susceptible R. anatipestifer strain by conjugation, as well as by natural 
transformation. These prerequisites make R. anatipestifer the most prolific reservoir of mo-
bile tet(X) genes. The corresponding reservoirs in Gammaproteobacteria are less under-
stood but presumably they are similar, although apparently not as abundant. However, 
some representatives of these bacteria were very successful in the role of pathogens, and 
they possess highly sophisticated natural genetic engineering tools. These provisions 
make them formidable opponents, especially in light of the acquisition of resistance to 
drugs of last resort. Some of the ESKAPE bacteria such as A. baumannii, K. pneumoniae and 
P. aeruginosa have already acquired the tet(X) genes that confer resistance to the recently 
approved next-generation tetracyclines. This may severely limit our options to control 
these pathogens.  
The widespread presence of different variants of Tex X in R. anatipestifer (Figures 1 
and 2) suggests that there is a positive selection for these tetracycline-resistant genes. Alt-
hough why have other tet genes not been selected under the same selective pressure? Do 
these FMOs confer some sort of selective advantage beyond tetracycline resistance? It has 
been shown, for example, that knocking out the tigecycline-resistant genes in R. anati-
pestifer results in a decrease in bacterial metabolic activity [68]. In general, however, the 
proportion of the tet(X) genes is quite small within the known and computed diversity of 
all tetracycline-resistant genes [68]. Additionally, there is no indication of tet(X) entry into 
Gram-positive bacteria. Is it because the natural pool of FMOs in these bacteria is rather 
Figure 3. Schematic representation of tet(X) evolution.
An initial step in the process of acquisition of obile resistance towards all tetra-
cyclines could have been the in situ selection and enrichment of natural reservoirs of
tet(X) in order to reach the critical threshold density, which is crucial for MGEs to operate
via conjugation mechanisms and provide successful HGT. This enrichment, especially in
flavobacteria and Gammaproteobacteria, probably resulted from the extensive selection
by older tetracyclines, and most likely in agricultural settings where they are mainly used,
both in proportional and absolute terms. Analysis of the tet(X) diversity (Figures 1 and 2)
demonstrated that it largely resid s within R. anatipestifer. A recent retrospective scre ning
of 212 R. anatipestifer isolates from 58 large-scale duck farms in different r gi ns of China
demonstrated that 90.6% of them are resistant to tetracycline [11]. Interestingly, 80.2% of
these isolates possessed the tet(X) gene, while the next most frequent tetracycline-resistant
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gene, tet(A), was encountered only in 20.8% of isolates. Moreover, if isolates that carry
tet(X) were counted in combination with other tetracycline-resistant genes, the total tet(X)-
carriage rate by this bacterium reaches 99.6%. Moreover, tet(X) could be transferred to a
tetracycline-susceptible R. anatipestifer strain by conjugation, as well as by natural trans-
formation. These prerequisites make R. anatipestifer the most prolific reservoir of mobile
tet(X) genes. The corresponding reservoirs in Gammaproteobacteria are less understood
but presumably they are similar, although apparently not as abundant. However, some
representatives of these bacteria were very successful in the role of pathogens, and they
possess highly sophisticated natural genetic engineering tools. These provisions make
them formidable opponents, especially in light of the acquisition of resistance to drugs
of last resort. Some of the ESKAPE bacteria such as A. baumannii, K. pneumoniae and
P. aeruginosa have already acquired the tet(X) genes that confer resistance to the recently
approved next-generation tetracyclines. This may severely limit our options to control
these pathogens.
The widespread presence of different variants of Tex X in R. anatipestifer (Figures 1 and 2)
suggests that there is a positive selection for these tetracycline-resistant genes. Although why
have other tet genes not been selected under the same selective pressure? Do these FMOs
confer some sort of selective advantage beyond tetracycline resistance? It has been shown,
for example, that knocking out the tigecycline-resistant genes in R. anatipestifer results in a
decrease in bacterial metabolic activity [68]. In general, however, the proportion of the tet(X)
genes is quite small within the known and computed diversity of all tetracycline-resistant
genes [69]. Additionally, there is no indication of tet(X) entry into Gram-positive bacteria. Is it
because the natural pool of FMOs in these bacteria is rather limited? Or is the bottleneck in
the MGEs of Gram-positive bacteria? These questions merit further investigation for better
understanding of AMR evolution.
7. Conclusions
Witnessing the rise and dissemination of high-level resistance towards the next-
generation tetracyclines within the last decade gave us a unique opportunity to understand
some key aspects of AMR evolution. Initially, non-specific AMR mechanisms are involved
that are chromosomally encoded, non-transferable, and can provide only low-level resis-
tance. Continuous reshuffling of genetic material among different ecological compartments
via MGEs and HGT may bring a chance of encountering gene(s) that are good at protect-
ing the host against antimicrobials (high-level resistance) and easily transferable. Then,
these selected genes can be transferred to other microbiotas, including pathogenic. Can
this chain of events be interrupted? This is possible, but it requires careful rethinking
of and alterations in the current supply chains [44]. The complexity of the problem re-
quires concerted efforts at various levels, including research, education, governmental
and regulatory agencies, health professionals, veterinarians, agricultural specialists, and
other stakeholders.
Funding: This research received no external funding.
Conflicts of Interest: The author declares no conflict of interest.
References
1. Levy, S.B.; McMurry, L.M.; Barbosa, T.M.; Burdett, V.; Courvalin, P.; Hillen, W.; Roberts, M.C.; Rood, J.I.; Taylor, D.E. Nomenclature
for New Tetracycline Resistance Determinants. Antimicrob. Agents Chemother. 1999, 43, 1523–1524. [CrossRef] [PubMed]
2. Aminov, R.I. The role of antibiotics and antibiotic resistance in nature. Environ. Microbiol. 2009, 11, 2970–2988. [CrossRef]
[PubMed]
3. Yang, W.; Moore, I.F.; Koteva, K.P.; Bareich, D.C.; Hughes, D.W.; Wright, G.D. TetX Is a Flavin-dependent Monooxygenase
Conferring Resistance to Tetracycline Antibiotics. J. Biol. Chem. 2004, 279, 52346–52352. [CrossRef]
4. Moore, I.F.; Hughes, D.W.; Wright, G.D. Tigecycline Is Modified by the Flavin-Dependent Monooxygenase TetX. Biochemistry
2005, 44, 11829–11835. [CrossRef] [PubMed]
5. Aminov, R.I. Evolution in action: Dissemination of tet(X) into pathogenic microbiota. Front. Microbiol. 2013, 4, 192. [CrossRef]
[PubMed]
Int. J. Mol. Sci. 2021, 22, 3905 12 of 14
6. Leski, T.A.; Bangura, U.; Jimmy, D.H.; Ansumana, R.; Lizewski, S.E.; Stenger, D.A.; Taitt, C.R.; Vora, G.J. Multidrug-resistant
tet(X)-containing hospital isolates in Sierra Leone. Int. J. Antimicrob. Agents 2013, 42, 83–86. [CrossRef] [PubMed]
7. Chen, Y.P.; Tsao, M.Y.; Lee, S.H.; Chou, C.H.; Tsai, H.J. Prevalence and molecular characterization of chloramphenicol resistance
in Riemerella anatipestifer isolated from ducks and geese in Taiwan. Avian Pathol. 2010, 39, 333–338. [CrossRef]
8. Sandhu, T.S.; Rimler, R.B. Riemerella anatipestifer infection. In Diseases of Poultry, 10th ed.; Calnek, B.W., Barnes, H.J., Beard, H.J.,
McDougald, L.R., Saif, Y.M., Eds.; Iowa State University Press: Ames, IA, USA, 1997; pp. 161–166.
9. Ryll, M.; Christensen, H.; Bisgaard, M.; Christensen, J.P.; Hinz, K.H.; Kohler, B. Studies on the prevalence of Riemerella anatipestifer
in the upper respiratory tract of clinically healthy ducklings and characterization of untypable strains. J. Vet. Med. 2001, 48,
537–546. [CrossRef]
10. Sarver, C.F.; Morishita, T.Y.; Nersessian, B. The Effect of Route of Inoculation and Challenge Dosage on Riemerella anatipestifer
Infection in Pekin Ducks (Anas platyrhynchos). Avian Dis. 2005, 49, 104–107. [CrossRef] [PubMed]
11. Zhu, D.-K.; Luo, H.-Y.; Liu, M.-F.; Zhao, X.-X.; Jia, R.-Y.; Chen, S.; Sun, K.-F.; Yang, Q.; Wu, Y.; Chen, X.-Y.; et al. Various Profiles
of tet Genes Addition to tet(X) in Riemerella anatipestifer Isolates from Ducks in China. Front. Microbiol. 2018, 9, 585. [CrossRef]
[PubMed]
12. Koike, S.; Mackie, R.; Aminov, R.I. Chapter 8: Agricultural use of antibiotics and antibiotic resistance. In Antibiotic Resistance
Genes in Natural Environments and Long-Term Effects; Mirete, S., Pérez, M.L., de Ardoz, T., Eds.; Nova Science Publishers, Inc.:
Hauppauge, NY, USA, 2017; pp. 217–250.
13. Aminov, R.I. Horizontal Gene Exchange in Environmental Microbiota. Front. Microbiol. 2011, 2, 158. [CrossRef] [PubMed]
14. Landers, T.F.; Cohen, B.; Wittum, T.E.; Larson, E.L. A Review of Antibiotic Use in Food Animals: Perspective, Policy, and Potential.
Public Health Rep. 2012, 127, 4–22. [CrossRef] [PubMed]
15. He, T.; Wang, R.; Liu, D.; Walsh, T.R.; Zhang, R.; Lv, Y.; Ke, Y.; Ji, Q.; Wei, R.; Liu, Z.; et al. Emergence of plasmid-mediated
high-level tigecycline resistance genes in animals and humans. Nat. Microbiol. 2019, 4, 1450–1456. [CrossRef]
16. Sun, J.; Chen, C.; Cui, C.-Y.; Zhang, Y.; Liu, X.; Cui, Z.-H.; Ma, X.-Y.; Feng, Y.-J.; Fang, L.-X.; Lian, X.-L.; et al. Plasmid-encoded
tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat. Microbiol. 2019, 4, 1457–1464. [CrossRef] [PubMed]
17. Sun, C.; Cui, M.; Zhang, S.; Wang, H.; Song, L.; Zhang, C.; Zhao, Q.; Liu, D.; Wang, Y.; Shen, J.; et al. Plasmid-mediated
tigecycline-resistant gene tet(X4) in Escherichia coli from food-producing animals, China, 2008–2018. Emerg. Microb. Infect. 2019, 8,
1524–1527. [CrossRef]
18. Zhang, R.; Dong, N.; Shen, Z.; Zeng, Y.; Lu, J.; Liu, C.; Zhou, H.; Hu, Y.; Sun, Q.; Cheng, Q.; et al. Epidemiological and
phylogenetic analysis reveals Flavobacteriaceae as potential ancestral source of tigecycline resistance gene tet(X). Nat. Commun.
2020, 11, 1–13. [CrossRef] [PubMed]
19. Chen, C.; Cui, C.-Y.; Yu, J.-J.; He, Q.; Wu, X.-T.; He, Y.-Z.; Cui, Z.-H.; Li, C.; Jia, Q.-L.; Shen, X.-G.; et al. Genetic diversity and
characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species. Genome Med. 2020, 12, 1–13. [CrossRef] [PubMed]
20. He, D.; Wang, L.; Zhao, S.; Liu, L.; Liu, J.; Hu, G.; Pan, Y. A novel tigecycline resistance gene, tet(X6), on an SXT/R391 integrative
and conjugative element in a Proteus genomospecies 6 isolate of retail meat origin. J. Antimicrob. Chemother. 2020, 75, 1159–1164.
[CrossRef] [PubMed]
21. Liu, D.; Zhai, W.; Song, H.; Fu, Y.; Schwarz, S.; He, T.; Bai, L.; Wang, Y.; Walsh, T.R.; Shen, J. Identification of the novel tigecycline
resistance gene tet(X6) and its variants in Myroides, Acinetobacter and Proteus of food animal origin. J. Antimicrob. Chemother. 2020,
75, 1428–1431. [CrossRef]
22. Chen, C.; Cui, C.-Y.; Wu, X.-T.; Fang, L.-X.; He, Q.; He, B.; Long, T.-F.; Liao, X.-P.; Chen, L.; Liu, Y.-H.; et al. Spread of tet(X5) and
tet(X6) genes in multidrug-resistant Acinetobacter baumannii strains of animal origin. Vet. Microbiol. 2021, 253, 108954. [CrossRef]
23. Fang, L.; Chen, C.; Cui, C.; Li, X.; Zhang, Y.; Liao, X.; Sun, J.; Liu, Y. Emerging High-Level Tigecycline Resistance: Novel
Tetracycline Destructases Spread via the Mobile Tet(X). BioEssays 2020, 42, e2000014. [CrossRef] [PubMed]
24. Li, R.; Lu, X.; Peng, K.; Liu, Z.; Li, Y.; Liu, Y.; Xiao, X.; Wang, Z. Deciphering the Structural Diversity and Classification of the
Mobile Tigecycline Resistance Gene tet(X)-Bearing Plasmidome among Bacteria. mSystems 2020, 5. [CrossRef]
25. Zhanel, G.G.; Cheung, D.; Adam, H.; Zelenitsky, S.; Golden, A.; Schweizer, F.; Gorityala, B.; Lagacé-Wiens, P.R.S.; Walkty, A.; Gin,
A.S.; et al. Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent. Drugs 2016, 76, 567–588. [CrossRef]
26. Tanaka, S.K.; Steenbergen, J.; Villano, S. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcy-
cline antibiotic. Bioorganic Med. Chem. 2016, 24, 6409–6419. [CrossRef] [PubMed]
27. Andrei, S.; Droc, G.; Stefan, G. FDA approved antibacterial drugs: 2018–2019. Discoveries 2019, 7, e102. [CrossRef] [PubMed]
28. Wang, L.; Liu, D.; Lv, Y.; Cui, L.; Li, Y.; Li, T.; Song, H.; Hao, Y.; Shen, J.; Wang, Y.; et al. Novel plasmid-mediated tet(X5)
gene conferring resistance to tigecycline, eravacycline and omadacycline in clinical Acinetobacter baumannii. Antimicrob. Agents
Chemother. 2019, 64, 01326-19. [CrossRef] [PubMed]
29. Cheng, Y.; Chen, Y.; Liu, Y.; Guo, Y.; Zhou, Y.; Xiao, T.; Zhang, S.; Xu, H.; Chen, Y.; Shan, T.; et al. Identification of novel tetracycline
resistance gene tet(X14) and its co-occurrence with tet(X2) in a tigecycline-resistant and colistin-resistant Empedobacter stercoris.
Emerg. Microbes Infect. 2020, 9, 1843–1852. [CrossRef] [PubMed]
30. Gasparrini, A.J.; Markley, J.L.; Kumar, H.; Wang, B.; Fang, L.; Irum, S.; Symister, C.T.; Wallace, M.; Burnham, C.-A.D.; Andleeb, S.;
et al. Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum
tetracycline resistance. Commun. Biol. 2020, 3, 1–12. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2021, 22, 3905 13 of 14
31. Huijbers, M.M.; Montersino, S.; Westphal, A.H.; Tischler, D.; Van Berkel, W.J. Flavin dependent monooxygenases. Arch. Biochem.
Biophys. 2014, 544, 2–17. [CrossRef] [PubMed]
32. Reis, R.A.; Li, H.; Johnson, M.; Sobrado, P. New frontiers in flavin-dependent monooxygenases. Arch. Biochem. Biophys. 2021, 699,
108765. [CrossRef] [PubMed]
33. Andersen, S.J.; Quan, S.; Gowan, B.; Dabbs, E.R. Monooxygenase-like sequence of a Rhodococcus equi gene confer-ring increased
resistance to rifampin by inactivating this antibiotic. Antimicrob. Agents Chemother. 1997, 41, 218–221. [CrossRef] [PubMed]
34. Hoshino, Y.; Fujii, S.; Shinonaga, H.; Arai, K.; Saito, F.; Fukai, T.; Satoh, H.; Miyazaki, Y.; Ishikawa, J. Monooxygenation of
rifampicin catalyzed by the rox gene product of Nocardia farcinica: Structure elucidation, gene identification and role in drug
resistance. J. Antibiot. 2010, 63, 23–28. [CrossRef] [PubMed]
35. Liu, L.-K.; Dai, Y.; Abdelwahab, H.; Sobrado, P.; Tanner, J.J. Structural evidence for rifampicin monooxygenase inactivating
rifampicin by cleaving its ansabridge. Biochemistry 2018, 57, 2065–2068. [CrossRef] [PubMed]
36. Minerdi, D.; Zgrablic, I.; Castrignanò, S.; Catucci, G.; Medana, C.; Terlizzi, M.E.; Gribaudo, G.; Gilardi, G.; Sadeghi, S.J. Escherichia
coli overexpressing a baeyer-villiger monooxygenase from Acinetobacter radioresistens becomes resistant to imipenem. Antimicrob.
Agents Chemother. 2016, 60, 64–74. [CrossRef]
37. Wise, E.M., Jr.; Abou-Donia, M.M. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-
resistant dihydropteroate synthases. Proc. Natl. Acad. Sci. USA 1975, 72, 2621–2625. [CrossRef] [PubMed]
38. Ricken, B.; Kolvenbach, B.A.; Bergesch, C.; Benndorf, D.; Kroll, K.; Strnad, H.; Vlček, Č.; Adaixo, R.; Hammes, F.; Shahgaldian, P.;
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